Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.
This study has been terminated.
( Strategic decision )
Study NCT00741741 Information provided by Tibotec Pharmaceuticals, Ireland
First Received on August 22, 2008. Last Updated on October 22, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Sponsors listed in this trial
Tibotec Pharmaceuticals, Ireland
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers